$GKOS
GLAUKOS Corp Stock $gkos

$gkos Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000155837024001630 Filed on February 23, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$85.62M	$82.37M	$314.7M
YoY Change	15.86%	15.64%	11.26%
Cost Of Revenue	$20.26M	$18.89M	$75.58M
YoY Change	12.1%	9.69%	9.56%
Gross Profit	$65.36M	$63.47M	$239.1M
YoY Change	17.08%	17.53%	11.81%
Gross Profit Margin	76.34%	77.06%	75.99%
Selling, General & Admin	$61.98M	$63.03M	$224.1M
YoY Change	15.52%	21.39%	16.14%
% of Gross Profit	94.82%	99.31%	93.7%
Research & Development	$30.73M	$39.06M	$138.8M
YoY Change	-12.64%	9.08%	12.57%
% of Gross Profit	47.01%	61.54%	58.03%
Depreciation & Amortization	$2.685M	$8.514M	$33.65M
YoY Change	29.21%	4.06%	6.58%
% of Gross Profit	4.11%	13.41%	14.07%
Operating Expenses	$92.70M	$102.1M	$367.8M
YoY Change	4.37%	16.36%	24.19%
Operating Profit	-$27.34M	-$38.62M	-$128.7M
YoY Change	-17.14%	14.49%	56.35%
Interest Expense	-$367.0K	-$516.0K	$13.63M
YoY Change	-110.77%	-78.93%	-0.63%
% of Operating Profit
Other Income/Expense, Net	-$1.028M	$2.420M	-$5.027M
YoY Change	-16.56%	-5.91%	-68.81%
Pretax Income	-$40.46M	-$36.72M	-$133.7M
YoY Change	18.22%	17.83%	35.86%
Income Tax	$377.0K	$61.00K	$934.0K
% Of Pretax Income
Net Earnings	-$40.84M	-$36.78M	-$134.7M
YoY Change	17.94%	16.91%	35.79%
Net Earnings / Revenue	-47.7%	-44.65%	-42.8%
Basic Earnings Per Share	-$0.82		-$2.78
Diluted Earnings Per Share	-$0.82	-$0.75	-$2.78
COMMON SHARES
Basic Shares Outstanding	49.47M	48.80M	48.43M
Diluted Shares Outstanding	49.58M		48.43M

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$272.9M	$295.4M	$295.4M
YoY Change	-14.13%	-16.24%	-16.24%
Cash & Equivalents	$42.50M	$93.47M	$93.47M
Short-Term Investments	$230.4M	$202.0M	$202.0M
Other Short-Term Assets	$19.02M	$18.19M	$18.19M
YoY Change	-3.96%	5.47%	5.47%
Inventory	$50.19M	$41.99M	$41.99M
Prepaid Expenses
Receivables	$46.55M	$39.85M	$39.85M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$388.6M	$395.5M	$395.5M
YoY Change	-6.56%	-10.9%	-10.9%
LONG-TERM ASSETS
Property, Plant & Equipment	$172.1M	$103.2M	$174.5M
YoY Change	75.04%	9.33%	4.62%
Goodwill	$66.13M	$66.13M
YoY Change	0.0%	0.0%
Intangibles	$281.9M	$283.0M
YoY Change	-6.54%	-8.09%
Long-Term Investments
YoY Change
Other Assets	$24.56M	$21.33M	$21.33M
YoY Change	36.66%	20.54%	20.54%
Total Long-Term Assets	$544.7M	$545.0M	$545.0M
YoY Change	-2.15%	-2.43%	-2.43%
TOTAL ASSETS
Total Short-Term Assets	$388.6M	$395.5M	$395.5M
Total Long-Term Assets	$544.7M	$545.0M	$545.0M
Total Assets	$933.3M	$940.4M	$940.4M
YoY Change	-4.04%	-6.18%	-6.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$12.75M	$13.44M	$13.44M
YoY Change	6.01%	-6.69%	-6.69%
Accrued Expenses	$59.49M	$60.57M	$60.57M
YoY Change	18.11%	4.52%	4.52%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$72.24M	$74.01M	$74.01M
YoY Change	15.78%	2.29%	2.29%
LONG-TERM LIABILITIES
Long-Term Debt	$353.4M	$353.3M	$353.3M
YoY Change	-0.1%	-0.07%	-0.07%
Other Long-Term Liabilities	$49.82M	$13.75M	$44.18M
YoY Change	345.38%	33.8%	12.75%
Total Long-Term Liabilities	$403.2M	$13.75M	$397.5M
YoY Change	3504.74%	33.8%	1.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$72.24M	$74.01M	$74.01M
Total Long-Term Liabilities	$403.2M	$13.75M	$397.5M
Total Liabilities	$482.6M	$478.6M	$478.6M
YoY Change	3.99%	1.33%	1.33%
SHAREHOLDERS EQUITY
Retained Earnings	-$639.9M	-$599.1M
YoY Change	28.23%	29.0%
Common Stock	$1.089B	$1.060B
YoY Change	7.96%	6.24%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$450.7M	$461.8M	$461.8M
YoY Change
Total Liabilities & Shareholders Equity	$933.3M	$940.4M	$940.4M
YoY Change	-4.04%	-6.18%	-6.18%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$40.84M	-$36.78M	-$134.7M
YoY Change	17.94%	16.91%	35.79%
Depreciation, Depletion And Amortization	$2.685M	$8.514M	$33.65M
YoY Change	29.21%	4.06%	6.58%
Cash From Operating Activities	-$33.87M	-$10.67M	-$57.80M
YoY Change	10.1%	157.93%	74.62%
INVESTING ACTIVITIES
Capital Expenditures	$968.0K	$4.218M	$20.25M
YoY Change	-85.99%	-48.69%	-33.1%
Acquisitions
YoY Change
Other Investing Activities	-$28.42M	-$8.707M	$34.34M
YoY Change	310.38%	-135.0%	-54.24%
Cash From Investing Activities	-$29.38M	-$12.92M	$14.10M
YoY Change	112.43%	-177.6%	-68.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	13.17M	7.302M	15.04M
YoY Change	1042.97%	1280.34%	140.63%
NET CHANGE
Cash From Operating Activities	-33.87M	-10.67M	-57.80M
Cash From Investing Activities	-29.38M	-12.92M	14.10M
Cash From Financing Activities	13.17M	7.302M	15.04M
Net Change In Cash	-50.97M	-16.29M	-27.28M
YoY Change	18.19%	-224.85%	-265.54%
FREE CASH FLOW
Cash From Operating Activities	-$33.87M	-$10.67M	-$57.80M
Capital Expenditures	$968.0K	$4.218M	$20.25M
Free Cash Flow	-$34.84M	-$14.89M	-$78.05M
YoY Change	-7.52%	20.47%	23.17%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.78
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.09
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.07
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48433000
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	47444000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	46423000
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2021	gkos	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2022	gkos	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2023	gkos	Defined Contribution Plan Employers Matching Contribution Vesting Period DefinedContributionPlanEmployersMatchingContributionVestingPeriod	P3Y
CY2021	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2022	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2023	us-gaap	Defined Contribution Plan Employer Matching Contribution Percent DefinedContributionPlanEmployerMatchingContributionPercent	0.50
CY2022Q4	us-gaap	Trading Securities TradingSecurities	0
CY2023Q4	us-gaap	Trading Securities TradingSecurities	0
CY2023Q4	gkos	Number Of Months Of Lease Term For Adjustments Of Letters Of Credit Balance Outstanding To Begin NumberOfMonthsOfLeaseTermForAdjustmentsOfLettersOfCreditBalanceOutstandingToBegin	37
CY2023	dei	Entity Registrant Name EntityRegistrantName	GLAUKOS Corp
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001192448
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2022Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-37463
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	33-0945406
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	One Glaukos Way
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Aliso Viejo
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92656
CY2023	dei	City Area Code CityAreaCode	949
CY2023	dei	Local Phone Number LocalPhoneNumber	367-9600
CY2023	dei	Security12b Title Security12bTitle	Common Stock
CY2023	dei	Trading Symbol TradingSymbol	GKOS
CY2023	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	3445000000
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	49470423
CY2023	dei	Auditor Firm AuditorFirmId	42
CY2023	dei	Auditor Name AuditorName	Ernst & Young LLP
CY2023	dei	Auditor Location AuditorLocation	Irvine, California
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93467000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119525000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	201964000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	233170000
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	39850000
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	36073000
CY2023Q4	us-gaap	Inventory Net InventoryNet	41986000
CY2022Q4	us-gaap	Inventory Net InventoryNet	37841000
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	18194000
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	17250000
CY2023Q4	us-gaap	Assets Current AssetsCurrent	395461000
CY2022Q4	us-gaap	Assets Current AssetsCurrent	443859000
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	5856000
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	7078000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103212000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94403000
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27146000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25826000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	44180000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	46601000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	282956000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	307869000
CY2023Q4	us-gaap	Goodwill Goodwill	66134000
CY2022Q4	us-gaap	Goodwill Goodwill	66134000
CY2023Q4	gkos	Deposit Assets And Other Assets Noncurrent DepositAssetsAndOtherAssetsNoncurrent	15469000
CY2022Q4	gkos	Deposit Assets And Other Assets Noncurrent DepositAssetsAndOtherAssetsNoncurrent	10613000
CY2023Q4	us-gaap	Assets Assets	940414000
CY2022Q4	us-gaap	Assets Assets	1002383000
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	13440000
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	14403000
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	60574000
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57956000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	74014000
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	72359000
CY2023Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	282773000
CY2022Q4	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	281400000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30427000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28905000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70538000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	72172000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7144000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	7264000
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	13752000
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	10278000
CY2023Q4	us-gaap	Liabilities Liabilities	478648000
CY2022Q4	us-gaap	Liabilities Liabilities	472378000
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	49148000
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	47782000
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	49120000
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47754000
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	49000
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	48000
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1059751000
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	997470000
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16116000
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-16395000
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	1165000
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-2975000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-599067000
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-464406000
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28000
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	28000
CY2023Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	132000
CY2022Q4	us-gaap	Treasury Stock Common Value TreasuryStockCommonValue	132000
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	461766000
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	530005000
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	940414000
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1002383000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	314711000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	282862000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294011000
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	75575000
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	68979000
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	66627000
CY2023	us-gaap	Gross Profit GrossProfit	239136000
CY2022	us-gaap	Gross Profit GrossProfit	213883000
CY2021	us-gaap	Gross Profit GrossProfit	227384000
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	224068000
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	192925000
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	179257000
CY2023	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	138768000
CY2022	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	123271000
CY2021	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	100999000
CY2023	gkos	Research And Development In Process Expense ResearchAndDevelopmentInProcessExpense	5000000
CY2022	gkos	Research And Development In Process Expense ResearchAndDevelopmentInProcessExpense	10000000
CY2021	gkos	Research And Development In Process Expense ResearchAndDevelopmentInProcessExpense	10000000
CY2022	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	30000000
CY2021	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	30000000
CY2023	us-gaap	Operating Expenses OperatingExpenses	367836000
CY2022	us-gaap	Operating Expenses OperatingExpenses	296196000
CY2021	us-gaap	Operating Expenses OperatingExpenses	260256000
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-128700000
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-82313000
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-32872000
CY2023	us-gaap	Interest And Other Income InterestAndOtherIncome	9164000
CY2022	us-gaap	Interest And Other Income InterestAndOtherIncome	2375000
CY2021	us-gaap	Interest And Other Income InterestAndOtherIncome	1288000
CY2023	us-gaap	Interest Expense InterestExpense	13633000
CY2022	us-gaap	Interest Expense InterestExpense	13720000
CY2021	us-gaap	Interest Expense InterestExpense	13372000
CY2023	gkos	Interest And Other Expense Net InterestAndOtherExpenseNet	558000
CY2022	gkos	Interest And Other Expense Net InterestAndOtherExpenseNet	4771000
CY2021	gkos	Interest And Other Expense Net InterestAndOtherExpenseNet	4311000
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-5027000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-133727000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98429000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-49267000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	934000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	766000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134661000
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-99195000
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-49593000
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.78
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.09
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.07
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	48433000
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47444000
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	46423000
CY2023	us-gaap	Profit Loss ProfitLoss	-134661000
CY2022	us-gaap	Profit Loss ProfitLoss	-99195000
CY2021	us-gaap	Profit Loss ProfitLoss	-49593000
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-110000
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	985000
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	781000
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	4250000
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-3975000
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	-1770000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4140000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2990000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-989000
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-130521000
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-102185000
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-50582000
CY2020Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	667449000
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	27251000
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	30146000
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-989000
CY2021	us-gaap	Profit Loss ProfitLoss	-49593000
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	587151000
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	6478000
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	38561000
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-2990000
CY2022	us-gaap	Profit Loss ProfitLoss	-99195000
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	530005000
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	15754000
CY2023	gkos	Adjustments To Additional Paid In Capital Value Of Shares Issued For Acquired In Process Research And Development AdjustmentsToAdditionalPaidInCapitalValueOfSharesIssuedForAcquiredInProcessResearchAndDevelopment	3000000
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	43528000
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	4140000
CY2023	us-gaap	Profit Loss ProfitLoss	-134661000
CY2023Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	461766000
CY2023	us-gaap	Profit Loss ProfitLoss	-134661000
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24912000
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24912000
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	24912000
CY2023	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4324000
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4370000
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	4760000
CY2022	us-gaap	Profit Loss ProfitLoss	-99195000
CY2021	us-gaap	Profit Loss ProfitLoss	-49593000
CY2023	us-gaap	Depreciation Depreciation	8742000
CY2022	us-gaap	Depreciation Depreciation	6664000
CY2021	us-gaap	Depreciation Depreciation	4749000
CY2023	gkos	Amortization Of Financing Cost AmortizationOfFinancingCost	1373000
CY2022	gkos	Amortization Of Financing Cost AmortizationOfFinancingCost	1373000
CY2021	gkos	Amortization Of Financing Cost AmortizationOfFinancingCost	1373000
CY2023	gkos	Change In Deferred Income Tax Expense Benefit ChangeInDeferredIncomeTaxExpenseBenefit	-120000
CY2022	gkos	Change In Deferred Income Tax Expense Benefit ChangeInDeferredIncomeTaxExpenseBenefit	-54000
CY2021	gkos	Change In Deferred Income Tax Expense Benefit ChangeInDeferredIncomeTaxExpenseBenefit	-1029000
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-893000
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	24000
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-7000
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	43528000
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	38561000
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	30146000
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	980000
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2242000
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-2313000
CY2023	gkos	Amortization Of Discount On Short Term Investments AmortizationOfDiscountOnShortTermInvestments	-1685000
CY2022	gkos	Amortization Of Discount On Short Term Investments AmortizationOfDiscountOnShortTermInvestments	731000
CY2021	gkos	Amortization Of Discount On Short Term Investments AmortizationOfDiscountOnShortTermInvestments	1028000
CY2023	gkos	Increase Decrease In Others Accrued Liabilities IncreaseDecreaseInOthersAccruedLiabilities	3049000
CY2022	gkos	Increase Decrease In Others Accrued Liabilities IncreaseDecreaseInOthersAccruedLiabilities	785000
CY2021	gkos	Increase Decrease In Others Accrued Liabilities IncreaseDecreaseInOthersAccruedLiabilities	2465000
CY2023	gkos	In Process Research And Development Acquired Through Issuance Of Stock InProcessResearchAndDevelopmentAcquiredThroughIssuanceOfStock	3000000
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3843000
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3138000
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1700000
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	4830000
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	15472000
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	7703000
CY2023	gkos	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-885000
CY2022	gkos	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-1720000
CY2021	gkos	Increase Decrease In Prepaid Expense And Other Current Assets IncreaseDecreaseInPrepaidExpenseAndOtherCurrentAssets	-3054000
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1305000
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7210000
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	12448000
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	1880000
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	328000
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-186000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57758000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33083000
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	24708000
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20248000
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	30265000
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	47785000
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	265587000
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	59256000
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	215285000
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	303100000
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	135157000
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	206916000
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	151000
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	3000
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	14095000
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44779000
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-58232000
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	12748000
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	3577000
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	26124000
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	6278000
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	5630000
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	4817000
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3273000
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2730000
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3690000
CY2022	gkos	Proceeds From Tenant Allowance ProceedsFromTenantAllowance	301000
CY2021	gkos	Proceeds From Tenant Allowance ProceedsFromTenantAllowance	12668000
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	711000
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	527000
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	659000
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	15042000
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6251000
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	39260000
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1341000
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1468000
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1774000
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-27280000
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16479000
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	3962000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126603000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110124000
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	106162000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99323000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126603000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110124000
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1333000
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	3797000
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2263000
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1557000
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	522000
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	272000
CY2023	gkos	Interest Paid Net Convertible Senior Notes InterestPaidNetConvertibleSeniorNotes	7906000
CY2022	gkos	Interest Paid Net Convertible Senior Notes InterestPaidNetConvertibleSeniorNotes	7906000
CY2021	gkos	Interest Paid Net Convertible Senior Notes InterestPaidNetConvertibleSeniorNotes	7907000
CY2023	us-gaap	Interest Paid Net InterestPaidNet	4348000
CY2022	us-gaap	Interest Paid Net InterestPaidNet	4434000
CY2021	us-gaap	Interest Paid Net InterestPaidNet	4074000
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-134700000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-57800000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-599100000
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 12pt 0pt;"><span style="font-style:italic;font-weight:bold;">Use of Estimates</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates, judgments and assumptions that affect the reported amounts in the consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates and assumptions used in the preparation of the accompanying consolidated financial statements under different assumptions and conditions. </p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 12pt 0pt;">The Company’s consolidated financial statements as of and for the year ended December 31, 2023 reflect the Company’s estimates of the impact of the macroeconomic environment, including the impact of inflation, supply shortages or delays, changes in supply and demand, bank failures, foreign exchange rate fluctuations and other conditions which have led to disruptions in commerce and pricing stability.<span style="color:#0000ff;"> </span>The Company is not aware of any specific event or circumstance that would require an update to its estimates, judgments and assumptions or a revision of the carrying value of the Company’s assets or liabilities as of December 31, 2023.</p>
CY2023	gkos	Number Of Business Activities NumberOfBusinessActivities	1
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	93467000
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	119525000
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	100708000
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	5856000
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	7078000
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	9416000
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	99323000
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	126603000
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	110124000
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;margin:0pt 0pt 9pt 0pt;"><span style="font-style:italic;font-weight:bold;">Concentration of Credit Risk and Significant Customers</span></p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-indent:36pt;margin:0pt 0pt 9pt 0pt;">Financial instruments, which potentially subject the Company to significant concentration of credit risk, consist primarily of cash, cash equivalents, short-term investments and accounts receivable. The Company maintains deposits in federally insured financial institutions in the U.S. in excess of federally insured limits and management believes that the Company is not exposed to significant credit risk due to the financial position of the depository institutions in which those deposits are held. Additionally, the Company has established guidelines regarding investment instruments and their maturities which are designed to maintain preservation of principal and liquidity. The Company believes that the concentration of credit risk in its accounts receivable is mitigated by its credit evaluation process, relatively short collection terms and the level of credit worthiness of its customers. During the years ended 2023, 2022 and 2021, none of the Company’s customers accounted for more than 10% of revenues. </p>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1200000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1300000
CY2021	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0
CY2023	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0
CY2023	gkos	Number Of Performance Obligations For Majority Of Contracts With Customers NumberOfPerformanceObligationsForMajorityOfContractsWithCustomers	1
CY2023	gkos	Standard Warranty Period StandardWarrantyPeriod	P1Y
CY2023	us-gaap	Advertising Expense AdvertisingExpense	3400000
CY2022	us-gaap	Advertising Expense AdvertisingExpense	2500000
CY2021	us-gaap	Advertising Expense AdvertisingExpense	1200000
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8483000
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8440000
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8827000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	gkos	Number Of Votes Per Common Share NumberOfVotesPerCommonShare	1
CY2023Q4	gkos	Number Of Votes Per Common Share NumberOfVotesPerCommonShare	1
CY2023Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	202271000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	441000
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	748000
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	201964000
CY2022Q4	us-gaap	Debt Securities Available For Sale Amortized Cost After Allowance For Credit Loss DebtSecuritiesAvailableForSaleAmortizedCostAfterAllowanceForCreditLoss	237724000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	3000
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	4557000
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	233170000
CY2023Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	41051000
CY2022Q4	us-gaap	Accounts Receivable Gross AccountsReceivableGross	37323000
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1201000
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1250000
CY2023Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	39850000
CY2022Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	36073000
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	16699000
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	13742000
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	12870000
CY2022Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	10495000
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	12417000
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	13604000
CY2023Q4	us-gaap	Inventory Gross InventoryGross	41986000
CY2022Q4	us-gaap	Inventory Gross InventoryGross	37841000
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	137689000
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	121627000
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	34477000
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	27224000
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103212000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94403000
CY2023Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	20588000
CY2022Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	17219000
CY2023Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	5269000
CY2022Q4	us-gaap	Accrued Vacation Current AccruedVacationCurrent	4475000
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	34717000
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	36262000
CY2023Q4	gkos	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	60574000
CY2022Q4	gkos	Accrued Liabilities And Employee Related Liabilities Current AccruedLiabilitiesAndEmployeeRelatedLiabilitiesCurrent	57956000
CY2022Q4	gkos	Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount	0
CY2023Q4	gkos	Fair Value Assets And Liabilities Level1 Level2 And Level3 Transfers Amount FairValueAssetsAndLiabilitiesLevel1Level2AndLevel3TransfersAmount	0
CY2023	us-gaap	Lessee Operating Lease Existence Of Option To Extend LesseeOperatingLeaseExistenceOfOptionToExtend	true
CY2023	gkos	Lessee Leasing Arrangements Operating Leases Number Of Most Significant Leases Expiring LesseeLeasingArrangementsOperatingLeasesNumberOfMostSignificantLeasesExpiring	2
CY2023	gkos	Lessee Leasing Arrangements Operating Leases Number Of Most Significant Leases Expiring LesseeLeasingArrangementsOperatingLeasesNumberOfMostSignificantLeasesExpiring	2
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	27146000
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	25826000
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	44180000
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	46601000
CY2023Q4	gkos	Lease Right Of Use Asset LeaseRightOfUseAsset	71326000
CY2022Q4	gkos	Lease Right Of Use Asset LeaseRightOfUseAsset	72427000
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1309000
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	430000
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	923000
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	30427000
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	28905000
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	70538000
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	72172000
CY2023Q4	gkos	Finance And Operating Lease Liability FinanceAndOperatingLeaseLiability	103197000
CY2022Q4	gkos	Finance And Operating Lease Liability FinanceAndOperatingLeaseLiability	101507000
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2421000
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	2421000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4310000
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	4347000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	3949000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	5184000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	3728000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	5340000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3732000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	5500000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3832000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	5665000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	3928000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	5835000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	32512000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	188969000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	96058000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	51681000
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	123582000
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	19945000
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	52121000
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	31736000
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	71461000
CY2023Q4	gkos	Lessee Operating Lease Option To Extend Value LesseeOperatingLeaseOptionToExtendValue	22600000
CY2023Q4	gkos	Lessee Financing Lease Option To Extend Value LesseeFinancingLeaseOptionToExtendValue	75800000
CY2023	us-gaap	Lessee Operating Lease Lease Not Yet Commenced Existence Of Option To Extend LesseeOperatingLeaseLeaseNotYetCommencedExistenceOfOptionToExtend	true
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P12Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P13Y3M18D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P18Y3M18D
CY2022Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P19Y3M18D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.080
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.060
CY2022Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.060
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3248000
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2931000
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	3126000
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	576000
CY2022	gkos	Net Right Of Use Asset Remeasurement Of Operating Lease NetRightOfUseAssetRemeasurementOfOperatingLease	-1007000
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	4310000
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	4347000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	266300000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	102244000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	164056000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	266300000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77331000
CY2023Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	385200000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	102244000
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	282956000
CY2022Q4	us-gaap	Intangible Assets Gross Excluding Goodwill IntangibleAssetsGrossExcludingGoodwill	385200000
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	77331000
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	307869000
CY2023Q4	us-gaap	Goodwill Goodwill	66134000
CY2023Q4	us-gaap	Goodwill Goodwill	66134000
CY2022Q4	us-gaap	Goodwill Goodwill	66134000
CY2022Q4	us-gaap	Goodwill Goodwill	66134000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	24618000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	22092000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	22092000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	22080000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	21548000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	51626000
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	164056000
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	314711000
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	282862000
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	294011000
CY2023	gkos	Period For Payment On Invoice Terms PeriodForPaymentOnInvoiceTerms	P30D
CY2023	us-gaap	Revenue Practical Expedient Financing Component RevenuePracticalExpedientFinancingComponent	true
CY2023	us-gaap	Revenue Practical Expedient Financing Component RevenuePracticalExpedientFinancingComponent	true
CY2023	us-gaap	Revenue Practical Expedient Incremental Cost Of Obtaining Contract RevenuePracticalExpedientIncrementalCostOfObtainingContract	true
CY2023Q4	gkos	Accrued Rebates Liabilities Current AccruedRebatesLiabilitiesCurrent	8900000
CY2022Q4	gkos	Accrued Rebates Liabilities Current AccruedRebatesLiabilitiesCurrent	7200000
CY2023	gkos	Share Based Compensation Number Of Plans ShareBasedCompensationNumberOfPlans	3
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P10Y
CY2023	gkos	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Percentage On First Anniversary Date Of Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPercentageOnFirstAnniversaryDateOfGrant	0.25
CY2023	gkos	Share Based Compensation Arrangement By Share Based Payment Award Award Remaining Vesting Period ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardRemainingVestingPeriod	P3Y
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	43528000
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	38561000
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	30146000
CY2023	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	5300000
CY2022	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	-500000
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	12300000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-138205000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-101316000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-51370000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4478000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2887000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	2103000
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-133727000
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-98429000
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-49267000
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-55000
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-240000
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	294000
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	368000
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	189000
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	815000
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	693000
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1162000
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1054000
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	821000
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1351000
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	23000
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	14000
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	264000
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-143000
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-87000
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1234000
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	18000
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-55000
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-120000
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-55000
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1025000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	934000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	766000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326000
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-28082000
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-20670000
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-10346000
CY2023	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-6436000
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-2558000
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-3395000
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	5105000
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	497000
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	4513000
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-5323000
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	493000
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-12310000
CY2023	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	6059000
CY2022	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	7700000
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	5408000
CY2023	gkos	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	3493000
CY2022	gkos	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	3711000
CY2021	gkos	Effective Income Tax Rate Reconciliation Uncertain Tax Positions Amount EffectiveIncomeTaxRateReconciliationUncertainTaxPositionsAmount	2685000
CY2023	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	1333000
CY2022	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	56000
CY2021	us-gaap	Income Tax Reconciliation Change In Enacted Tax Rate IncomeTaxReconciliationChangeInEnactedTaxRate	-802000
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	26937000
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	25389000
CY2023	gkos	Income Tax Reconciliation State Economic Development Credits IncomeTaxReconciliationStateEconomicDevelopmentCredits	2370000
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	39273000
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	934000
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	766000
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	326000
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	96886000
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	92158000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	26176000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	20978000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	14533000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	15142000
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	12111000
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	10410000
CY2023Q4	gkos	Deferred Tax Assets Tax Deferred Expense Lease Liability DeferredTaxAssetsTaxDeferredExpenseLeaseLiability	24924000
CY2022Q4	gkos	Deferred Tax Assets Tax Deferred Expense Lease Liability DeferredTaxAssetsTaxDeferredExpenseLeaseLiability	24749000
CY2023Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	48462000
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	25286000
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	957000
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2344000
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	224049000
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	191067000
CY2023Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	56471000
CY2022Q4	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	61404000
CY2023Q4	gkos	Deferred Tax Liabilities Deferred Expense Lease Assets DeferredTaxLiabilitiesDeferredExpenseLeaseAssets	17196000
CY2022Q4	gkos	Deferred Tax Liabilities Deferred Expense Lease Assets DeferredTaxLiabilitiesDeferredExpenseLeaseAssets	17645000
CY2023Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	73667000
CY2022Q4	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	79049000
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	157526000
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	119282000
CY2023Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7144000
CY2022Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	7264000
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	38200000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28968000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25816000
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	22803000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	986000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	679000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	505000
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4013000
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4307000
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3489000
CY2023	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1128000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	553000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	327000
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	1281000
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions	654000
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	32839000
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	28968000
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	25816000
CY2023Q4	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	2300000
CY2023Q4	gkos	Unrecognized Tax Benefits Expected To Be Recognized In Next Twelve Months UnrecognizedTaxBenefitsExpectedToBeRecognizedInNextTwelveMonths	400000
CY2023Q4	us-gaap	Deferred Tax Liability Not Recognized Amount Of Unrecognized Deferred Tax Liability Undistributed Earnings Of Foreign Subsidiaries DeferredTaxLiabilityNotRecognizedAmountOfUnrecognizedDeferredTaxLiabilityUndistributedEarningsOfForeignSubsidiaries	0
CY2023	us-gaap	Defined Contribution Plan Maximum Annual Contributions Per Employee Percent DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent	1
CY2023	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Age50 Or Less Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAge50OrLessAmount	22500
CY2022	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Age50 Or Less Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAge50OrLessAmount	20500
CY2021	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Age50 Or Less Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeAge50OrLessAmount	19500
CY2023	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Over Age50 Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeOverAge50Amount	30000
CY2022	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Over Age50 Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeOverAge50Amount	27000
CY2021	gkos	Defined Contribution Plan Maximum Annual Contributions Per Employee Over Age50 Amount DefinedContributionPlanMaximumAnnualContributionsPerEmployeeOverAge50Amount	26000
CY2021	gkos	Maximum Defined Contribution Plan Employer Matching Contribution Percent MaximumDefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2022	gkos	Maximum Defined Contribution Plan Employer Matching Contribution Percent MaximumDefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2023	gkos	Maximum Defined Contribution Plan Employer Matching Contribution Percent MaximumDefinedContributionPlanEmployerMatchingContributionPercent	0.06
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2900000
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2500000
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	2100000
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	11300000
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	8200000
CY2023Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	11600000
CY2022Q4	us-gaap	Deferred Compensation Plan Assets DeferredCompensationPlanAssets	8400000
CY2023Q4	gkos	Restricted Cash Pledged For Letter Of Credit RestrictedCashPledgedForLetterOfCredit	5600000
CY2022Q4	gkos	Restricted Cash Pledged For Letter Of Credit RestrictedCashPledgedForLetterOfCredit	6800000
CY2018Q4	gkos	Frequency Of Adjustments Of Letters Of Credit Balance Outstanding FrequencyOfAdjustmentsOfLettersOfCreditBalanceOutstanding	P12M
CY2023	gkos	Adjustment Percentage Of Letters Of Credit Balance Outstanding AdjustmentPercentageOfLettersOfCreditBalanceOutstanding	0.20
CY2023Q4	gkos	Minimal Amount Of Letters Of Credit Balance Outstanding After Adjustments MinimalAmountOfLettersOfCreditBalanceOutstandingAfterAdjustments	2000000.0
CY2023Q4	gkos	Restricted Cash Pledged For Office Lease Agreement RestrictedCashPledgedForOfficeLeaseAgreement	300000
CY2023Q4	gkos	Purchase Obligation Due After Twelve Months PurchaseObligationDueAfterTwelveMonths	4500000
CY2023	gkos	Number Of Business Activities NumberOfBusinessActivities	1
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	103212000
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	94403000
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	68969000
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	33654000
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	31576000
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	29661000
CY2023	gkos	Capital Expenditure CapitalExpenditure	20248000
CY2022	gkos	Capital Expenditure CapitalExpenditure	30265000
CY2021	gkos	Capital Expenditure CapitalExpenditure	47785000
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001558370-24-001630-index-headers.html	Edgar Link	pending
0001558370-24-001630-index.html	Edgar Link	pending
0001558370-24-001630.txt	Edgar Link	pending
0001558370-24-001630-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
gkos-20231231.xsd	Edgar Link	pending
gkos-20231231x10k.htm	Edgar Link	pending
gkos-20231231x10k001.jpg	Edgar Link	pending
gkos-20231231xex10d23.htm	Edgar Link	pending
gkos-20231231xex21.htm	Edgar Link	pending
gkos-20231231xex23d1.htm	Edgar Link	pending
gkos-20231231xex31d1.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
gkos-20231231x10k_htm.xml	Edgar Link	completed
gkos-20231231xex31d2.htm	Edgar Link	pending
gkos-20231231xex32d1.htm	Edgar Link	pending
gkos-20231231xex32d2.htm	Edgar Link	pending
gkos-20231231xex97.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
gkos-20231231_def.xml	Edgar Link	unprocessable
gkos-20231231_lab.xml	Edgar Link	unprocessable
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
gkos-20231231_cal.xml	Edgar Link	unprocessable
gkos-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$GKOS
GLAUKOS Corp Stock $gkos

2024 Q1 Form 10-K Financial Statement

#000155837024001630 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GKOS GLAUKOS Corp Stock $gkos

2024 Q1 Form 10-K Financial Statement

#000155837024001630 Filed on February 23, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$GKOS
GLAUKOS Corp Stock $gkos